feed,title,long_url,short_url
Nasdaq,PZZA Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/pzza-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3iEilkH
Nasdaq,Quidel Reaches Analyst Target Price,https://www.nasdaq.com/articles/quidel-reaches-analyst-target-price-2021-07-23,https://j.mp/3hYhV9y
Nasdaq,LULU Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/lulu-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3kSbA1d
Nasdaq,JKHY Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/jkhy-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3rsA5mQ
Nasdaq,MSFT Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/msft-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3iCuerf
Nasdaq,ADBE Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/adbe-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3y1pphG
Nasdaq,5 Dividend Aristocrats Where Analysts See Capital Gains,https://www.nasdaq.com/articles/5-dividend-aristocrats-where-analysts-see-capital-gains-2021-07-23,https://j.mp/3y6T09C
Nasdaq,FE Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/fe-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3eNZhz6
Nasdaq,Square Reaches Analyst Target Price,https://www.nasdaq.com/articles/square-reaches-analyst-target-price-2021-07-23,https://j.mp/2Wcm3ue
Nasdaq,TYL Crosses Above Average Analyst Target,https://www.nasdaq.com/articles/tyl-crosses-above-average-analyst-target-2021-07-23,https://j.mp/3iD91xf
Nasdaq,How The Pieces Add Up: DVY Targets $126,https://www.nasdaq.com/articles/how-the-pieces-add-up%3A-dvy-targets-%24126-2021-07-23,https://j.mp/2W7BR17
Nasdaq,Veeva Systems Reaches Analyst Target Price,https://www.nasdaq.com/articles/veeva-systems-reaches-analyst-target-price-2021-07-23,https://j.mp/2TtjPpa
Nasdaq,Tech SPAC Belong Acquisition prices $150 million IPO,https://www.nasdaq.com/articles/tech-spac-belong-acquisition-prices-%24150-million-ipo-2021-07-23,https://j.mp/3BxrEvh
Nasdaq,Swiss health tech company SOPHiA GENETICS prices US IPO at $18 midpoint,https://www.nasdaq.com/articles/swiss-health-tech-company-sophia-genetics-prices-us-ipo-at-%2418-midpoint-2021-07-23,https://j.mp/3zxFCLX
Nasdaq,3 Reasons ETFs Should Be on Your Shopping List,https://www.nasdaq.com/articles/3-reasons-etfs-should-be-on-your-shopping-list-2021-07-23,https://j.mp/3iHx0eK
